CoChat

Oxytocin in the socioemotional brain: implications for psychiatric disorders

Open access
Kirsch, Peter · 2015 · Dialogues in Clinical Neuroscience
Cited by 120

The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.

Abstract

The neuropeptide oxytocin (OXT), highly conserved during evolution, is an important modulator of social and emotional processes across many species. During the last decade, a large body of literature has revealed its effects on different aspects of social behavior, including social stress and anxiety, social memory, affiliation and bonding, emotion recognition, mentalizing, empathy, and interpersonal trust. In addition, as impairments in these social domains can be observed in a number of neuropsychiatric disorders, such as autism, social anxiety disorder, depression, schizophrenia, and borderline personality disorder, the role of OXT in mental disorders and their treatment has been intensively studied. The present paper gives a short overview of these lines of research and shows how OXT has become a promising target for novel treatment approaches for mental disorders characterized by social impairments.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.31887/dcns.2015.17.4/pkirsch

Cites

99 of 99 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Research works printed but not linked: 46

  1. Sauer C., 2012, Neuropsychopharmacology., 37, 1474, 10.1038/npp.2011.333 · DOI
  2. Brothers L., 1990, Concepts Neurosci., 1, 27
  3. Altemus M., 1995, J Clin Endocrinol Metab., 80, 2954
  4. Michaud K., 2008, Stress., 11, 177, 10.1080/10253890701727874 · DOI · Paper page
  5. Wirth MM., 2015, Neuropsychobiology., 71, 202, 10.1159/000381023 · DOI
  6. Clark-Elford R., 2014, Int J Neuropsychopharmacol. doi:10.1093/ijnp/pyu012, 18 · DOI · Paper page
  7. Herzmann G., 2012, Brain Res., 1451, 65, 10.1016/j.brainres.2012.02.049 · DOI · Paper page
  8. van Ast VA., 2013, Psychoneuroendocrinology., 38, 1874, 10.1016/j.psyneuen.2013.06.012 · DOI
  9. Wirth MM., 2015, Adapt Human Behav Physiol., 1, 177, 10.1007/s40750-014-0010-4 · DOI
  10. Edwards S., 2006, Neurosci., 9, 7
  11. Insel TR., 2000, Rev Gen Psychol., 4, 176, 10.1037/1089-2680.4.2.176 · doi:10.1037/1089-2680.4.2.176 · Paper page
  12. Domes G., 2007, Biol Psychiatry., 61, 731, 10.1016/j.biopsych.2006.07.015 · DOI · Paper page
  13. Luminet O., 2011, BiolPsychol., 87, 401
  14. Krueger F., 2012, Front Hum Neurosci., 6, 4
  15. Mikolajczak M., 2010, Biological-psychology., 85, 182, 10.1016/j.biopsycho.2010.05.010 · DOI
  16. Bujanow W., 1972, BMJ., 4, 298, 10.1136/bmj.4.5835.298-c · DOI · Paper page
  17. Bujanow W., 1974, Can Psychiatr Assoc J., 19, 323, 10.1177/070674377401900323 · DOI
  18. Modahl C., 1992, J Autism Dev Disord., 22, 449, 10.1007/BF01048246 · DOI
  19. Cuthbert BN., 2015, Dialogues Clin Neurosci., 17, 89, 10.31887/DCNS.2015.17.1/bcuthbert · DOI · Paper page
  20. Wu S., 2005, Biol Psychiatry., 58, 74, 10.1016/j.biopsych.2005.03.013 · DOI · Paper page
  21. Tansey KE., 2010, Neurosci Lett., 474, 163, 10.1016/j.neulet.2010.03.035 · DOI
  22. Connolly JJ., 2013, Child Dev., 84, 17, 10.1111/j.1467-8624.2012.01838.x · DOI · Paper page
  23. Lerer E., 2010, Autism Res., 3, 293, 10.1002/aur.156 · DOI · Paper page
  24. Guastella AJ., 2010, Biol Psychiatry., 67, 692, 10.1016/j.biopsych.2009.09.020 · DOI · Paper page
  25. Hoge EA., 2012, Depress Anxiety., 29, 924, 10.1002/da.21973 · DOI · Paper page
  26. Hoge EA., 2008, CNS Neurosci Ther., 14, 165, 10.1111/j.1755-5949.2008.00051.x · DOI · Paper page
  27. Beckmann H., 1985, Psychoneuroendocrinology., 10, 187, 10.1016/0306-4530(85)90056-3 · DOI
  28. Glovinsky D., 1994, Schizophr Res., 11, 273, 10.1016/0920-9964(94)90021-3 · DOI
  29. Goldman M., 2008, Schizophr Res., 98, 247, 10.1016/j.schres.2007.09.019 · DOI · Paper page
  30. Legros JJ., 1992, Psychoneuroendocrinology., 17, 611, 10.1016/0306-4530(92)90019-4 · DOI
  31. Feifel D., 1999, Psychopharmacology (Berl)., 141, 93, 10.1007/s002130050811 · DOI
  32. Lee PR., 2005, Neuropsychopharmacology., 30, 1883, 10.1038/sj.npp.1300722 · DOI · Paper page
  33. Modabbernia A., 2013, CNS Drugs., 27, 57, 10.1007/s40263-012-0022-1 · DOI
  34. Averbeck BB., 2012, Psychol Med., 42, 259, 10.1017/S0033291711001413 · DOI · Paper page
  35. Shin NY., 2015, Neuropsychopharmacology., 40, 1919, 10.1038/npp.2015.41 · DOI
  36. Fischer-Shofty M., 2013, Front Neurosci., 7, 127, 10.3389/fnins.2013.00127 · DOI · Paper page
  37. Yuen KW., 2014, J Psychiatr Res., 51, 30, 10.1016/j.jpsychires.2013.12.012 · DOI · Paper page
  38. McQuaid RJ., 2013, Front Neurosci., 7, 128, 10.3389/fnins.2013.00128 · DOI · Paper page
  39. Jonas W., 2013, Genes Brain Behav., 12, 681, 10.1111/gbb.12069 · DOI · Paper page
  40. Myers AJ., 2014, J Psychiatr Res., 59, 93, 10.1016/j.jpsychires.2014.08.021 · DOI · Paper page
  41. Meisenberg G., 1981, Peptides., 2, 1, 10.1016/S0196-9781(81)80003-4 · DOI
  42. Scantamburlo G., 2011, J Neuropsychiatry Clin Neurosci., 23, E5, 10.1176/jnp.23.2.jnpe5 · doi:10.1176/jnp.23.2.jnpe5
  43. Mah BL., 2013, Prog Neuropsychopharmacol Biol Psychiatry., 40, 267, 10.1016/j.pnpbp.2012.10.005 · DOI
  44. Stanley B., 2010, Am J Psychiatry., 167, 24, 10.1176/appi.ajp.2009.09050744 · DOI · Paper page
  45. Jobst A., 2014, Psychother Psychosom., 83, 252, 10.1159/000358526 · DOI · Paper page
  46. Simeon D., 2011, Psychoneuroendocrinology., 36, 1418, 10.1016/j.psyneuen.2011.03.013 · DOI · Paper page

Cited by

See all 120

Metadata

Authors
Kirsch, P.
Venue
Dialogues in Clinical Neuroscience
Published
2015-12-31
Volume
17
Issue
4
Pages
463-476
ISSN
  • 1294-8322 (ISSN-L)
  • 1958-5969
OpenAlex
W2280009904
Cited by
120
References
99
FWCI
18.25
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.